These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 30176817)

  • 1. Pipeline for specific subtype amplification and drug resistance detection in hepatitis C virus.
    Soria ME; Gregori J; Chen Q; García-Cehic D; Llorens M; de Ávila AI; Beach NM; Domingo E; Rodríguez-Frías F; Buti M; Esteban R; Esteban JI; Quer J; Perales C
    BMC Infect Dis; 2018 Sep; 18(1):446. PubMed ID: 30176817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global epidemiology of HCV subtypes and resistance-associated substitutions evaluated by sequencing-based subtype analyses.
    Welzel TM; Bhardwaj N; Hedskog C; Chodavarapu K; Camus G; McNally J; Brainard D; Miller MD; Mo H; Svarovskaia E; Jacobson I; Zeuzem S; Agarwal K
    J Hepatol; 2017 Aug; 67(2):224-236. PubMed ID: 28343981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of hepatitis C virus for determination of subtypes and detection of resistance mutations to protease inhibitors in a group of intravenous drug users co-infected with HIV.
    Silva T; Cortes Martins H; Coutinho R; Leitão E; Silva R; Pádua E
    J Med Virol; 2015 Sep; 87(9):1549-57. PubMed ID: 25940586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of a Template-Independent Next-Generation Sequencing Assay for Detecting Low-Level Resistance-Associated Variants of Hepatitis C Virus.
    Wei B; Kang J; Kibukawa M; Chen L; Qiu P; Lahser F; Marton M; Levitan D
    J Mol Diagn; 2016 Sep; 18(5):643-656. PubMed ID: 27393904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Preexisting Hepatitis C Virus Genotype 6 NS3, NS5A, and NS5B Polymorphisms on the
    McPhee F; Ueland J; Vellucci V; Bowden S; Sievert W; Zhou N
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30718256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Net emergence of substitutions at position 28 in NS5A of hepatitis C virus genotype 4 in patients failing direct-acting antivirals detected by next-generation sequencing.
    Nguyen T; Akhavan S; Caby F; Bonyhay L; Larrouy L; Gervais A; Lebray P; Poynard T; Calmus Y; Simon A; Valantin MA; Calvez V; Marcelin AG; Todesco E
    Int J Antimicrob Agents; 2019 Jan; 53(1):80-83. PubMed ID: 30236959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino Acid Substitutions Associated with Treatment Failure for Hepatitis C Virus Infection.
    Soria ME; García-Crespo C; Martínez-González B; Vázquez-Sirvent L; Lobo-Vega R; de Ávila AI; Gallego I; Chen Q; García-Cehic D; Llorens-Revull M; Briones C; Gómez J; Ferrer-Orta C; Verdaguer N; Gregori J; Rodríguez-Frías F; Buti M; Esteban JI; Domingo E; Quer J; Perales C
    J Clin Microbiol; 2020 Nov; 58(12):. PubMed ID: 32999010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms and resistance mutations of hepatitis C virus on sequences in the European hepatitis C virus database.
    Kliemann DA; Tovo CV; da Veiga AB; de Mattos AA; Wood C
    World J Gastroenterol; 2016 Oct; 22(40):8910-8917. PubMed ID: 27833382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance assessment of a fully automated deep sequencing platform for HCV resistance testing.
    Rodriguez C; Mercier-Darty M; Soulier A; Poiteau L; Wlassow M; Fourati S; Hézode C; Pawlotsky JM; Chevaliez S
    Antivir Ther; 2019; 24(6):417-423. PubMed ID: 31112134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of amino acid mutations in hepatitis C virus core and NS5B regions among Venezuelan viral isolates and comparison with worldwide isolates.
    Jaspe RC; Sulbarán YF; Sulbarán MZ; Loureiro CL; Rangel HR; Pujol FH
    Virol J; 2012 Sep; 9():214. PubMed ID: 22995142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels.
    Di Maio VC; Cento V; Di Paolo D; Aragri M; De Leonardis F; Tontodonati M; Micheli V; Bellocchi MC; Antonucci FP; Bertoli A; Lenci I; Milana M; Gianserra L; Melis M; Di Biagio A; Sarrecchia C; Sarmati L; Landonio S; Francioso S; Lambiase L; Nicolini LA; Marenco S; Nosotti L; Giannelli V; Siciliano M; Romagnoli D; Pellicelli A; Vecchiet J; Magni CF; Babudieri S; Mura MS; Taliani G; Mastroianni C; Vespasiani-Gentilucci U; Romano M; Morisco F; Gasbarrini A; Vullo V; Bruno S; Baiguera C; Pasquazzi C; Tisone G; Picciotto A; Andreoni M; Parruti G; Rizzardini G; Angelico M; Perno CF; Ceccherini-Silberstein F;
    J Antimicrob Chemother; 2016 Mar; 71(3):739-50. PubMed ID: 26679249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance-associated substitutions (RASs) to HCV direct-acting antivirals (DAAs) at baseline of treatment in thalassemia patients: a referral center study.
    Safarnezhad Tameshkel F; Karbalaie Niya MH; Zamani F; Motamed N; Ajdarkosh H; Vafaeimanesh J; Khoonsari M; Sohrabi MR; Aten S; Azarkeivan A; Eslami MS; Perumal D; Maadi M; Ghanbari B; Keyvani H
    Arch Virol; 2020 Oct; 165(10):2193-2203. PubMed ID: 32638116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of hepatitis C virus for subtype determination and resistance-associated substitutions detection among Chinese voluntary blood donors.
    Jiang X; Lv X; Chang L; Yan Y; Ji H; Sun H; Guo F; Rodgers MA; Yin P; Wang L
    Antiviral Res; 2020 Sep; 181():104871. PubMed ID: 32717286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of resistance-associated substitutions in hepatitis C virus sequences from Kyrgyzstan].
    Kartashov MY; Svirin KA; Bekbolotov AA; Momusheva KT; Iskanova BM; Solpueva AS; Motorov UT; Narmatova EB; Krivosheina EI; Gladysheva AV; Chub EV; Gashnikova NM
    Vopr Virusol; 2023 Jul; 68(3):265-270. PubMed ID: 37436417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HCV genotype-1 subtypes and resistance-associated substitutions in drug-naive and in direct-acting antiviral treatment failure patients.
    Gozlan Y; Ben-Ari Z; Moscona R; Shirazi R; Rakovsky A; Kabat A; Veizman E; Berdichevski T; Weiss P; Cohen-Ezra O; Lurie Y; Gafanovich I; Braun M; Cohen-Naftaly M; Shlomai A; Shibolet O; Zigmond E; Zuckerman E; Carmiel-Haggai M; Nimer A; Hazzan R; Maor Y; Kitay-Cohen Y; Shemer-Avni Y; Kra-Oz Z; Schreiber L; Peleg O; Sierra S; Harrigan PR; Mendelson E; Mor O
    Antivir Ther; 2017; 22(5):431-441. PubMed ID: 28067632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A translational study of resistance emergence using sequential direct-acting antiviral agents for hepatitis C using ultra-deep sequencing.
    Abe H; Hayes CN; Hiraga N; Imamura M; Tsuge M; Miki D; Takahashi S; Ochi H; Chayama K
    Am J Gastroenterol; 2013 Sep; 108(9):1464-72. PubMed ID: 23896953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similar prevalence of low-abundance drug-resistant variants in treatment-naive patients with genotype 1a and 1b hepatitis C virus infections as determined by ultradeep pyrosequencing.
    Margeridon-Thermet S; Le Pogam S; Li L; Liu TF; Shulman N; Shafer RW; Najera I
    PLoS One; 2014; 9(8):e105569. PubMed ID: 25140696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic background for development of resistance mutations within the HCV NS3 protease-helicase in direct acting antiviral naive patients.
    Grammatikos G; Jabara CB; Ahmad MQ; Herrmann E; Zeuzem S; Welsch C
    Antivir Ther; 2014; 19(5):455-61. PubMed ID: 24457994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suboptimal SVR rates in African patients with atypical genotype 1 subtypes: Implications for global elimination of hepatitis C.
    Childs K; Davis C; Cannon M; Montague S; Filipe A; Tong L; Simmonds P; Smith D; Thomson EC; Dusheiko G; Agarwal K
    J Hepatol; 2019 Dec; 71(6):1099-1105. PubMed ID: 31400349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Barrier to Direct Acting Antivirals in HCV Sequences Deposited in the European Databank.
    Kliemann DA; Tovo CV; Gorini da Veiga AB; Machado AL; West J
    PLoS One; 2016; 11(8):e0159924. PubMed ID: 27504952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.